IRCT20231017059748N1招募中3 期
Evaluation of colchicine effects in patients with sepsis: A double-blind, randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years(—)
- 性别
- All
入选标准
- •1- Sepsis patients 2 - Aged 18 to 80 years 3 - High CRP3 at baseline 4 - Consented patients
排除标准
- •1- Hypersensitivity to colchicine or other components of the formulation, 2- Hepatic failure (Child-Puff score B and C), 3- Renal failure (eGFR <15 mL/min/1.73 m2), 4- Malignancy, 5- Pregnancy, 6- Breastfeeding 7- Concomitant use of fusidic acid- lasmiditan- nirmatrelvir- pacritinib- fexinidazole.
研究者
相似试验
招募中
3 期
Effect of Colchicine in patient presenting with non ST-elevation myocardial infarctioIRCT20190601043780N1Mashhad University of Medical Sciences140
进行中(未招募)
1 期
Evaluation of the efficacy of colchicine with and without betamethasone mouthwash in the management of recurrent aphthous stomatitis - ART1Recurrent aphthous stomatitis (RAS)EUCTR2006-003327-36-GBGuy's & St Thomas' NHS Foundation Trust136
招募中
3 期
Evaluation of colchicine in treatment of coronavirusPulmonary infection of COVD19.Coronavirus infection, unspecifiedB34.2IRCT20200418047126N1Ardabil University of Medical Sciences100
尚未招募
Unknown
Clinical outcomes of colchicine therapy following percutaneous coronary intervention in patient s with acute coronary syndrome: the MACT (Mono Antiplatelet and Colchicine Therapy) prospective multicenter observational studyDiseases of the circulatory systemKCT0009444Bundang CHA General Hospital490
已完成
2 期
Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19COVID-19.COVID-19, virus identifiedU07.1IRCT20200325046854N2Iran University of Medical Sciences70
